Citius Pharmaceuticals In... (CTXR)
NASDAQ: CTXR
· Real-Time Price · USD
1.28
0.02 (1.59%)
At close: Aug 26, 2025, 12:09 PM
Citius Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Cash & Equivalents | 6.09M | 26.41K | 1.1M | 3.25M | 17.91M | 12.56M | 20.35M | 26.48M | 33.28M | 29.07M | 36.89M | 41.71M | 48.04M | 55.76M | 65.42M | 70.07M | 115.66M | 103.7M | 4.3M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 44.91M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 92.84M | 38.06K | 38.06K | 38.06K | 38.06K | 38.06K | 38.06K | 38.06K | 38.06K | 38.06K | 38.06K | 38.06K | 38.06K | 38.06K | 38.06K | 38.06K | 38.06K | 38.06K | 38.06K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | 17.21M | 15.34M | 14.38M | 8.27M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.31M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 24.61M | 18.37M | 18.33M | 14.22M | 28.01M | 21.57M | 28.21M | 34.37M | 41.11M | 34.9M | 42.32M | 44.56M | 50.83M | 58.26M | 67.94M | 72.81M | 116.94M | 104.97M | 5.58M |
Property-Plant & Equipment | 880.73K | 922.1K | 191.41K | 246.25K | 299.93K | 352.78K | 404.85K | 455.86K | 505.83K | 554.84K | 602.99K | 650.17K | 696.42K | 741.77K | 786.24K | 829.85K | 872.62K | 907.36K | 947.96K |
Goodwill & Intangibles | 9.35M | 102.15M | 102.15M | 102.15M | 68.75M | 68.75M | 68.75M | 68.75M | 68.75M | 68.75M | 68.75M | 68.75M | 68.75M | 68.75M | 68.75M | 68.75M | 28.75M | 28.75M | 28.75M |
Total Long-Term Assets | 103.07M | 103.11M | 102.38M | 102.43M | 69.08M | 69.14M | 69.19M | 69.24M | 69.29M | 69.34M | 69.39M | 69.44M | 69.48M | 69.53M | 69.57M | 69.61M | 29.66M | 29.69M | 29.73M |
Total Assets | 127.68M | 121.48M | 120.7M | 116.65M | 97.09M | 90.71M | 97.4M | 103.61M | 110.4M | 104.24M | 111.71M | 114M | 120.32M | 127.79M | 137.52M | 142.43M | 146.59M | 134.67M | 35.31M |
Account Payables | 10.09M | 9.37M | 7.36M | 4.93M | 1.66M | 2.67M | 2.65M | 2.93M | 3.08M | 2.73M | 1.54M | 1.17M | 1.69M | 1.71M | 1.79M | 1.28M | 1.35M | 1.13M | 984.17K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 114.69K | n/a | 204.57K | n/a | 235.58K | n/a | 224K | n/a | 212.87K | n/a | 202.18K | n/a | 191.9K | 186.92K | n/a | n/a | 164.58K | 340.91K | 172.97K |
Other Current Liabilities | 51.73M | 3.18M | 30.79M | n/a | 1.47M | 151.2K | 2.21M | n/a | 1.39M | 1.03M | 1.9M | n/a | 1.11M | 1.15M | 3.14M | n/a | n/a | 1M | n/a |
Total Current Liabilities | 51.84M | 49.88M | 44.81M | 35.81M | 4.15M | 4.17M | 5.58M | 5.78M | 5.79M | 6.21M | 4.54M | 4.53M | 4.46M | 4.02M | 7.34M | 3.98M | 3.6M | 2.98M | 3.55M |
Long-Term Debt | 766.96K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 164.58K | 164.58K |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 8.27M | 8.03M | 6.98M | 6.74M | 6.65M | 6.57M | 6.49M | 6.4M | 6.31M | 6.22M | 6.13M | 6.04M | 5.52M | 5.57M | 5.62M | 5.66M | 5.71M | 5.92M | 5.96M |
Total Liabilities | 60.12M | 57.91M | 51.78M | 42.55M | 10.81M | 10.74M | 12.07M | 12.18M | 12.1M | 12.43M | 10.67M | 10.57M | 9.98M | 9.59M | 12.96M | 9.65M | 9.31M | 8.9M | 9.51M |
Total Debt | 881.65K | 931.79K | 204.57K | 262.87K | 320.01K | 374.83K | 428.57K | 481.25K | 532.88K | 582.3K | 630.75K | 678.23K | 724.78K | 769.22K | 812.77K | 855.47K | 1.06M | 1.27M | 1.31M |
Common Stock | 14.47K | 8.76K | 7.73K | 7.25K | 180.72K | 159.09K | 158.97K | 158.86K | 158.86K | 146.36K | 146.21K | 146.21K | 146.13K | 146.13K | 146.03K | 145.98K | 145.98K | 134.7K | 55.58K |
Retained Earnings | -230.84M | -222.05M | -211.14M | -201.37M | -190.58M | -180.01M | -171.46M | -162.23M | -152.29M | -143.81M | -133.28M | -129.69M | -121.7M | -112.83M | -105.27M | -96.05M | -91.09M | -85.26M | -81.14M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | -0.00 | n/a | n/a | n/a | -0.00 | 0.00 | n/a | n/a | -0.00 | 0.00 | n/a | -0.00 | 210.42M | 0.00 |
Shareholders Equity | 65.06M | 60.66M | 65.41M | 70.08M | 85.68M | 79.37M | 84.73M | 90.83M | 97.7M | 91.21M | 100.43M | 102.83M | 109.74M | 117.6M | 123.96M | 132.18M | 136.68M | 125.16M | 25.2M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 44.91M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |